CORC  > 中国医学科学院 北京协和医学院
Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway
Fan, Hongjun; Yu, Xiying; Zou, Zhigeng; Zheng, Wei; Deng, Xin; Guo, Liping; Jiang, Wei; Zhan, Qimin; Lu, Shih-Hsin
2019
卷号40期号:5页码:669-679
ISSN号0143-3334
DOI10.1093/carcin/bgy160
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6345755
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Fan, Hongjun,Yu, Xiying,Zou, Zhigeng,et al. Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway[J],2019,40(5):669-679.
APA Fan, Hongjun.,Yu, Xiying.,Zou, Zhigeng.,Zheng, Wei.,Deng, Xin.,...&Lu, Shih-Hsin.(2019).Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway.,40(5),669-679.
MLA Fan, Hongjun,et al."Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway".40.5(2019):669-679.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace